Acute liver damage and ecstasy ingestion

Gut

Volumn 38, Issue 3, 1996, Pages 454-458

  Ellis, A J ^a   Wendon, J A ^a   Portmann, B ^a   Williams, Roger ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

3,4, methylenedioxymethamphetamine; Acute liver failure; Ecstacy; Hepatitis; MDMA; Transplantation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTHERMIA; HYPOTENSION; LIVER FAILURE; MALE; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0030006302     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.3.454     Document Type: Article

References (23)

1. Chadwick IS, Curry PD, Linsley A, Freemont AJ, Doran B. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 1991; 84: 371.
2. Tehan B, Hardern R, Bodenham A. Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve'). Anaesthesia 1993; 48: 507-10.
3. Manchanda S, Connolly MJ. Cerebral infarction in association with Ecstasy abuse. Postgrad Med J 1993; 69: 874-5.
4. Kessel B. Hyponatraemia after ingestion of ecstasy [Letter]. BMJ 1994; 308: 414.
5. Dowling GP, McDonough E, Bost RO, 'Eve' and 'Ecstasy'. A report of rive deaths associated with the use of MDEA and MDMA. JAMA 1987; 257: 1615-7.
6. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 1992; 340: 384-7.
7. Shearman JD, Chapman RW, Satsangi J, Ryley NG, Weatherhead S. Misuse of ecstasy [Letter]. BMJ 1992; 305: 309.
8. Gorard DA, Davies SE, Clark ML. Misuse of ecstasy [Letter]. BMJ 1992; 305: 301.
9. Brown C, Osterloh J. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') [Letter]. JAMA 1987; 258: 780-1.
10. Fahal IH, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after ecstasy. BMJ 1992; 305: 348.
11. deMan RA, Wilson JH, Tjen HS. Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy'). Med Tijdschr Geneeskd 1993; 137: 727-9.
12. Dykhuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith GC. Ecstasy induced hepatitis mimicking viral hepatitis. Gut 1995; 36: 939-41.
13. Shibolet S, Coll R, Gilat T, Sohar E. Heatstroke: its clinical picture and mechanism in 36 cases. Q J Med 1967; 36: 525-48.
14. O'Donnell TF. Acute heatstroke. Epidemiological, biochemical, renal and coagulation studies. JAMA 1975; 234: 824-8.
15. Olson KR, Benowitz NL. Environmental and drug induced hyperthermia. Pathophysiology, recognition and management. Emerg Med Clin North Am 1984; 2: 459-74.
16. Schmidt CJ, Black CK, Abbate GM, Taylor VL. MDMA-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res 1990; 529: 85-90.
17. Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermo-regulatory responses of the rat. Pharmacol Biochem Behav 1991; 38: 339-44.
18. Logan AS, Stickle B, O'Keefe N, Hewitson H. Survival following 'Ecstasy' ingestion with a peak temperature of 42 degrees C [Letter]. Anaesthesia 1993; 48: 1017-8.
19. Kim RC, Collins GH, Cho C, Ichikawa K, Givelber H. Heatstroke: report on three fatal cases with emphasis on findings in smooth muscle. Pathol Lab Med 1980; 104: 345-59.
20. Fidler S, Fagan EA, Williams R, Dewhurst I, Cory CE. Heatstroke and rhabdomyolysis presenting as fulminant hepatic failure. Postgrad Med J 1988; 64: 157-9.
21. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
22. Hassanein T, Perper JA, Tepperman L, Starzl TE, Van Thiel DH. Liver occurring as a component of exertional heatstroke. Gastroenterology 1991; 100: 1442-7.
23. Rubel LR, Ischak KG. The liver in fatal heat stroke. Liver 1983; 3: 249-60.